Jefferies Group LLC Halozyme Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $7.69 Million - $9.28 Million	-200,000 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$38.84 - $51.31 $7.77 Million - $10.3 Million	200,000 New	200,000 $9.08 Million
Q2 2021 Aug 20, 2021	SELL	$38.84 - $51.31 $769 Million - $1.02 Billion	-19,800,000 Reduced 99.0%	200,000 $9.08 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $777 Million - $1.03 Billion	20,000,000 New	20,000,000 $9.08 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.